Q3 2020 Holdings
Filed 2020-11-16 | 47 holdings | $59.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $20.1M | 130,000 | 33.6% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $9.3M | 1,250,000 | 15.5% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $8.1M | 550,000 | 13.6% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $6.7M | 1,950,000 | 11.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $6.1M | 175,000 | 10.3% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $4.7M | 200,000 | 7.9% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $2.6M | 200,000 | 4.4% |
| Biogen Inc(BIIB) | COM | 09062X103 | $1.2M | 4,200 | 2.0% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $628.0K | 250,000 | 1.1% |
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $50.3K | 451,000 | 0.1% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $27.7K | 1,950,000 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $19.6K | 1,050,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $18.9K | 575,000 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $18.5K | 525,000 | 0.0% |
| Constellation Pharmceticls I(CNST) | COM | 210373106 | $14.7K | 725,000 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $12.0K | 1,161,375 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $10.0K | 60,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $9.1K | 400,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $9.1K | 65,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $8.5K | 600,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $8.0K | 200,000 | 0.0% |
| Surface Oncology Inc | COM | 86877M209 | $6.9K | 1,000,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $6.9K | 225,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $6.3K | 425,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $5.6K | 1,000,000 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $5.4K | 200,000 | 0.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $5.0K | 805,556 | 0.0% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $4.9K | 265,000 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $4.4K | 350,000 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $4.2K | 825,000 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $3.7K | 115,000 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $3.6K | 425,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $3.6K | 325,000 | 0.0% |
| Nextcure Inc | COM | 65343E108 | $3.5K | 400,000 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $3.5K | 250,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $2.9K | 30,000 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $2.1K | 75,000 | 0.0% |
| Millendo Therapeutics Inc | COM | 60040X103 | $1.5K | 925,000 | 0.0% |
| Homology Medicines Inc | COM | 438083107 | $1.4K | 135,000 | 0.0% |
| IMV Inc | COM | 44974L103 | $1.4K | 325,000 | 0.0% |
| Graybug Vision Inc | COM SHS | 38942Q103 | $953 | 75,000 | 0.0% |
| Satsuma Pharmaceuticals Inc | COM | 80405P107 | $778 | 200,000 | 0.0% |
| Moderna Inc(MRNA) | COM | 60770K107 | $708 | 10,000 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $421 | 100,000 | 0.0% |
| Bristol-Myers Squibb Co(BMY-R) | RIGHT 99/99/9999 | 110122157 | $281 | 125,000 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $247 | 4,500 | 0.0% |